Delivery of Adipose-Derived Stem Cells Attenuates Adipose Tissue Inflammation and Insulin Resistance in Obese Mice Through Remodeling Macrophage Phenotypes

Stem Cells and Development

Volumn 24, Issue 17, 2015, Pages 2052-2064

  Shang, Qianwen ^a   Bai, Yang ^a   Wang, Guannan ^a   Song, Qiang ^b   Guo, Chun ^a   Zhang, Lining ^a   Wang, Qun ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CELL THERAPY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT3 PROTEIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CELL FRACTIONATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIET INDUCED OBESITY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; ENZYME INHIBITION; FILTERS AND MEMBRANES; INFLAMMATION; INSULIN RESISTANCE; LEAN BODY WEIGHT; MACROPHAGE; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; METABOLISM; MOUSE MUTANT; OBESITY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939248254     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0557     Document Type: Article

References (53)

1. Hossain P, B Kawar and M El Nahas. (2007). Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 356:213-215.
2. Flegal KM, MD Carroll, CL Ogden and LR Curtin. (2010). Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241.
3. Xu H, GT Barnes, Q Yang, G Tan, D Yang, CJ Chou, J Sole, A Nichols, JS Ross, LA Tartaglia and H Chen. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830.
4. Hotamisligil GS. (2006). Inflammation and metabolic disorders. Nature 444:860-867.
5. Lumeng CN and AR Saltiel. (2011). Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111-2117.
6. Weisberg SP, D McCann, M Desai, M Rosenbaum, RL Leibel and AW Ferrante. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808.
7. Reilly SM and AR Saltiel. (2014). Obesity: a complex role for adipose tissue macrophages. Nat Rev Endocrinol 10: 193-194.
8. Peraldi P, GS Hotamisligil, WA Buurman, MF White and BM Spiegelman. (1996). Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022.
9. Sica A and A Mantovani. (2012). Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122:787-795.
10. Chinetti-Gbaguidi G and B Staels. (2011). Macrophage polarization in metabolic disorders: functions and regulation. Curr Opin Lipidol 22:365-372.
11. Odegaard JI and A Chawla. (2013). Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 339:172-177.
12. Osborn O and JM Olefsky. (2012). The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18:363-374.
13. Lumeng CN, JL Bodzin and AR Saltiel. (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175-184.
14. Han JM and MK Levings. (2013). Immune regulation in obesity-associated adipose inflammation. J Immunol 191: 527-532.
15. Fujisaka S, I Usui, A Bukhari, M Ikutani, T Oya, Y Kanatani, K Tsuneyama, Y Nagai, K Takatsu, et al. (2009). Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58: 2574-2582.
16. Morris DL, K Singer and CN Lumeng. (2011). Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states. Curr Opin Clin Nutr Metab Care 14:341-346.
17. Strioga M, S Viswanathan, A Darinskas, O Slaby and J Michalek. (2012). Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 21:2724-2752.
18. Mizuno H, M Tobita and AC Uysal. (2012). Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30:804-810.
19. Schaffler A and C Buchler. (2007). Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25:818-827.
20. Nakagami H, R Morishita, K Maeda, Y Kikuchi, T Ogihara and Y Kaneda. (2006). Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 13:77-81.
21. Gonzalez MA, E Gonzalez-Rey, L Rico, D Buscher and M Delgado. (2009). Treatment of experimental arthritis by inducing immune tolerance with human adiposederived mesenchymal stem cells. Arthritis Rheum 60: 1006-1019.
22. Gonzalez MA, E Gonzalez-Rey, L Rico, D Buscher and M Delgado. (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978-989.
23. Gonzalez-Rey E, P Anderson, MA Gonzalez, L Rico, D Buscher and M Delgado. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929-939.
24. Bassi EJ, PM Moraes-Vieira, CS Moreira-Sa, DC Almeida, LM Vieira, CS Cunha, MI Hiyane, AS Basso, A Pacheco-Silva and NO Camara. (2012). Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes 61:2534-2545.
25. Prockop DJ and JY Oh. (2012). Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 20:14-20.
26. Zhang QZ, WR Su, SH Shi, P Wilder-Smith, AP Xiang, A Wong, AL Nguyen, CW Kwon and AD Le. (2010). Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28:1856-1868.
27. Maggini J, G Mirkin, I Bognanni, J Holmberg, IM Piazzon, I Nepomnaschy, H Costa, C Canones, S Raiden, M Vermeulen and JR Geffner. (2010). Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5:e9252.
28. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228.
29. Wang Q, Z Dong, X Liu, X Song, Q Song, Q Shang, Y Jiang, C Guo and L Zhang. (2013). Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance. Diabetes 62:4132-4143.
30. Lin CS, ZC Xin, CH Deng, H Ning, G Lin and TF Lue. (2010). Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol 25:807-815.
31. Laurencikiene J, T Skurk, A Kulyté, P Hedén, G Aström, E Sjölin, M Rydén, H Hauner and P Arner. (2011). Regulation of lipolysis in small and large fat cells of the same subject. J Clin Endocrinol Metab 96:E2045-E2049.
32. Tchkonia T, T Thomou, Y Zhu, I Karagiannides, C Pothoulakis, MD Jensen and JL Kirkland. (2013). Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 17:644-656.
33. Tran TT and CR Kahn. (2010). Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol 6:195-213.
34. Lee WY, KJ Park, YB Cho, SN Yoon, KH Song, DS Kim, SH Jung, M Kim, HW Yoo, et al. (2013). Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula. Stem Cells 31:2575-2581.
35. Shibasaki M, K Takahashi, T Itou, S Miyazawa, M Ito, J Kobayashi, H Bujo and Y Saito. (2002). Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha? Diabetologia 45:518-526.
36. Furuhashi M, N Ura, H Takizawa, D Yoshida, N Moniwa, H Murakami, K Higashiura and K Shimamoto. (2004). Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J Hypertens 22:1977-1982.
37. Miyazaki S, T Izawa, JE Ogasawara, T Sakurai, S Nomura, T Kizaki, H Ohno and T Komabayashi. (2010). Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin. Life Sci 86:691-698.
38. Guo KY, P Halo, RL Leibel and Y Zhang. (2004). Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am J Physiol Regul Integr Comp Physiol 287:R112-R119.
39. Zhang Y, KY Guo, PA Diaz, M Heo and RL Leibel. (2002). Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol 282:R226-R234.
40. Skurk T, C Alberti-Huber, C Herder and H Hauner. (2007). Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92:1023-1033.
41. LiuMand F Liu. (2010). Transcriptional and post-translational regulation of adiponectin. Biochem J 425:41-52.
42. Shehzad A, W Iqbal, O Shehzad and YS Lee. (2012). Adiponectin: regulation of its production and its role in human diseases. Hormones (Athens) 11:8-20.
43. Deng T, CJ Lyon, LJ Minze, J Lin, J Zou, JZ Liu, Y Ren, Z Yin, DJ Hamilton, et al. (2013). Class II major histocom-patibility complex plays an essential role in obesityinduced adipose inflammation. Cell Metab 17:411-422.
44. Schottelius AJG, MW Mayo, RB Sartor and AS Badwin. (1999). Interleukin-10 signaling blocks inhibitor of kappa B kinase activity and nuclear factor kappa B DNA binding. J Biol Chem 274:31868-31874.
45. Kim HJ, T Higashimori, SY Park, H Choi, JY Dong, YJ Kim, HL Noh, YR Cho, G Cline, YB Kim and JK Kim. (2004). Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060-1067.
46. Hong EG, HJ Ko, YR Cho, HJ Kim, ZX Ma, TY Yu, RH Friedline, E Kurt-Jones, R Finberg, et al. (2009). Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 58:2525-2535.
47. Han JM, SJ Patterson, M Speck, JA Ehses and MK Levings. (2014). Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J Immunol 192:623-629.
48. Nishimura S, I Manabe, S Takaki, M Nagasaki, M Otsu, H Yamashita, J Sugita, K Yoshimura, K Eto, et al. (2013). Adipose natural regulatory B cells negatively control adipose tissue inflammation. Cell Metab pii: S1550-4131(13)00386-0; DOI: 10.1016/j.cmet.2013.09.017.
49. Mauer J, B Chaurasia, J Goldau, MC Vogt, J Ruud, KD Nguyen, S Theurich, AC Hausen, J Schmitz, et al. (2014). Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol 15:423-430.
50. Covarrubias AJ and T Horng. (2014). IL-6 strikes a balance in metabolic inflammation. Cell Metab 19:898-899.
51. Osorio EY, BL Travi, AM da Cruz, OA Saldarriaga, AA Medina and PC Melby. (2014). Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis. PLoS Pathog 10:e1004165.
52. D'Alessio S, C Correale, C Tacconi, A Gandelli, G Pietrogrande, S Vetrano, M Genua, V Arena, A Spinelli, et al. (2014). VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest 124:3863-3878.
53. Wu D, AB Molofsky, HE Liang, RR Ricardo-Gonzalez, HA Jouihan, JK Bando, A Chawla and RM Locksley. (2011). Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332:243-247.